Cargando…

A Shaving Proteomic Approach to Unveil Surface Proteins Modulation of Multi-Drug Resistant Pseudomonas aeruginosa Strains Isolated From Cystic Fibrosis Patients

Cystic fibrosis (CF) is the most common rare disease caused by a mutation of the CF transmembrane conductance regulator gene encoding a channel protein of the apical membrane of epithelial cells leading to alteration of Na(+) and K(+) transport, hence inducing accumulation of dense and sticky mucus...

Descripción completa

Detalles Bibliográficos
Autores principales: Montemari, Anna Lisa, Marzano, Valeria, Essa, Nour, Levi Mortera, Stefano, Rossitto, Martina, Gardini, Simone, Selan, Laura, Vrenna, Gianluca, Onetti Muda, Andrea, Putignani, Lorenza, Fiscarelli, Ersilia Vita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959810/
https://www.ncbi.nlm.nih.gov/pubmed/35355602
http://dx.doi.org/10.3389/fmed.2022.818669
_version_ 1784677243027456000
author Montemari, Anna Lisa
Marzano, Valeria
Essa, Nour
Levi Mortera, Stefano
Rossitto, Martina
Gardini, Simone
Selan, Laura
Vrenna, Gianluca
Onetti Muda, Andrea
Putignani, Lorenza
Fiscarelli, Ersilia Vita
author_facet Montemari, Anna Lisa
Marzano, Valeria
Essa, Nour
Levi Mortera, Stefano
Rossitto, Martina
Gardini, Simone
Selan, Laura
Vrenna, Gianluca
Onetti Muda, Andrea
Putignani, Lorenza
Fiscarelli, Ersilia Vita
author_sort Montemari, Anna Lisa
collection PubMed
description Cystic fibrosis (CF) is the most common rare disease caused by a mutation of the CF transmembrane conductance regulator gene encoding a channel protein of the apical membrane of epithelial cells leading to alteration of Na(+) and K(+) transport, hence inducing accumulation of dense and sticky mucus and promoting recurrent airway infections. The most detected bacterium in CF patients is Pseudomonas aeruginosa (PA) which causes chronic colonization, requiring stringent antibiotic therapies that, in turn induces multi-drug resistance. Despite eradication attempts at the first infection, the bacterium is able to utilize several adaptation mechanisms to survive in hostile environments such as the CF lung. Its adaptive machinery includes modulation of surface molecules such as efflux pumps, flagellum, pili and other virulence factors. In the present study we compared surface protein expression of PA multi- and pan-drug resistant strains to wild-type antibiotic-sensitive strains, isolated from the airways of CF patients with chronic colonization and recent infection, respectively. After shaving with trypsin, microbial peptides were analyzed by tandem-mass spectrometry on a high-resolution platform that allowed the identification of 174 differentially modulated proteins localized in the region from extracellular space to cytoplasmic membrane. Biofilm assay was performed to characterize all 26 PA strains in term of biofilm production. Among the differentially expressed proteins, 17 were associated to the virulome (e.g., Tse2, Tse5, Tsi1, PilF, FliY, B-type flagellin, FliM, PyoS5), six to the resistome (e.g., OprJ, LptD) and five to the biofilm reservoir (e.g., AlgF, PlsD). The biofilm assay characterized chronic antibiotic-resistant isolates as weaker biofilm producers than wild-type strains. Our results suggest the loss of PA early virulence factors (e.g., pili and flagella) and later expression of virulence traits (e.g., secretion systems proteins) as an indicator of PA adaptation and persistence in the CF lung environment. To our knowledge, this is the first study that, applying a shaving proteomic approach, describes adaptation processes of a large collection of PA clinical strains isolated from CF patients in early and chronic infection phases.
format Online
Article
Text
id pubmed-8959810
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89598102022-03-29 A Shaving Proteomic Approach to Unveil Surface Proteins Modulation of Multi-Drug Resistant Pseudomonas aeruginosa Strains Isolated From Cystic Fibrosis Patients Montemari, Anna Lisa Marzano, Valeria Essa, Nour Levi Mortera, Stefano Rossitto, Martina Gardini, Simone Selan, Laura Vrenna, Gianluca Onetti Muda, Andrea Putignani, Lorenza Fiscarelli, Ersilia Vita Front Med (Lausanne) Medicine Cystic fibrosis (CF) is the most common rare disease caused by a mutation of the CF transmembrane conductance regulator gene encoding a channel protein of the apical membrane of epithelial cells leading to alteration of Na(+) and K(+) transport, hence inducing accumulation of dense and sticky mucus and promoting recurrent airway infections. The most detected bacterium in CF patients is Pseudomonas aeruginosa (PA) which causes chronic colonization, requiring stringent antibiotic therapies that, in turn induces multi-drug resistance. Despite eradication attempts at the first infection, the bacterium is able to utilize several adaptation mechanisms to survive in hostile environments such as the CF lung. Its adaptive machinery includes modulation of surface molecules such as efflux pumps, flagellum, pili and other virulence factors. In the present study we compared surface protein expression of PA multi- and pan-drug resistant strains to wild-type antibiotic-sensitive strains, isolated from the airways of CF patients with chronic colonization and recent infection, respectively. After shaving with trypsin, microbial peptides were analyzed by tandem-mass spectrometry on a high-resolution platform that allowed the identification of 174 differentially modulated proteins localized in the region from extracellular space to cytoplasmic membrane. Biofilm assay was performed to characterize all 26 PA strains in term of biofilm production. Among the differentially expressed proteins, 17 were associated to the virulome (e.g., Tse2, Tse5, Tsi1, PilF, FliY, B-type flagellin, FliM, PyoS5), six to the resistome (e.g., OprJ, LptD) and five to the biofilm reservoir (e.g., AlgF, PlsD). The biofilm assay characterized chronic antibiotic-resistant isolates as weaker biofilm producers than wild-type strains. Our results suggest the loss of PA early virulence factors (e.g., pili and flagella) and later expression of virulence traits (e.g., secretion systems proteins) as an indicator of PA adaptation and persistence in the CF lung environment. To our knowledge, this is the first study that, applying a shaving proteomic approach, describes adaptation processes of a large collection of PA clinical strains isolated from CF patients in early and chronic infection phases. Frontiers Media S.A. 2022-03-09 /pmc/articles/PMC8959810/ /pubmed/35355602 http://dx.doi.org/10.3389/fmed.2022.818669 Text en Copyright © 2022 Montemari, Marzano, Essa, Levi Mortera, Rossitto, Gardini, Selan, Vrenna, Onetti Muda, Putignani and Fiscarelli. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Montemari, Anna Lisa
Marzano, Valeria
Essa, Nour
Levi Mortera, Stefano
Rossitto, Martina
Gardini, Simone
Selan, Laura
Vrenna, Gianluca
Onetti Muda, Andrea
Putignani, Lorenza
Fiscarelli, Ersilia Vita
A Shaving Proteomic Approach to Unveil Surface Proteins Modulation of Multi-Drug Resistant Pseudomonas aeruginosa Strains Isolated From Cystic Fibrosis Patients
title A Shaving Proteomic Approach to Unveil Surface Proteins Modulation of Multi-Drug Resistant Pseudomonas aeruginosa Strains Isolated From Cystic Fibrosis Patients
title_full A Shaving Proteomic Approach to Unveil Surface Proteins Modulation of Multi-Drug Resistant Pseudomonas aeruginosa Strains Isolated From Cystic Fibrosis Patients
title_fullStr A Shaving Proteomic Approach to Unveil Surface Proteins Modulation of Multi-Drug Resistant Pseudomonas aeruginosa Strains Isolated From Cystic Fibrosis Patients
title_full_unstemmed A Shaving Proteomic Approach to Unveil Surface Proteins Modulation of Multi-Drug Resistant Pseudomonas aeruginosa Strains Isolated From Cystic Fibrosis Patients
title_short A Shaving Proteomic Approach to Unveil Surface Proteins Modulation of Multi-Drug Resistant Pseudomonas aeruginosa Strains Isolated From Cystic Fibrosis Patients
title_sort shaving proteomic approach to unveil surface proteins modulation of multi-drug resistant pseudomonas aeruginosa strains isolated from cystic fibrosis patients
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959810/
https://www.ncbi.nlm.nih.gov/pubmed/35355602
http://dx.doi.org/10.3389/fmed.2022.818669
work_keys_str_mv AT montemariannalisa ashavingproteomicapproachtounveilsurfaceproteinsmodulationofmultidrugresistantpseudomonasaeruginosastrainsisolatedfromcysticfibrosispatients
AT marzanovaleria ashavingproteomicapproachtounveilsurfaceproteinsmodulationofmultidrugresistantpseudomonasaeruginosastrainsisolatedfromcysticfibrosispatients
AT essanour ashavingproteomicapproachtounveilsurfaceproteinsmodulationofmultidrugresistantpseudomonasaeruginosastrainsisolatedfromcysticfibrosispatients
AT levimorterastefano ashavingproteomicapproachtounveilsurfaceproteinsmodulationofmultidrugresistantpseudomonasaeruginosastrainsisolatedfromcysticfibrosispatients
AT rossittomartina ashavingproteomicapproachtounveilsurfaceproteinsmodulationofmultidrugresistantpseudomonasaeruginosastrainsisolatedfromcysticfibrosispatients
AT gardinisimone ashavingproteomicapproachtounveilsurfaceproteinsmodulationofmultidrugresistantpseudomonasaeruginosastrainsisolatedfromcysticfibrosispatients
AT selanlaura ashavingproteomicapproachtounveilsurfaceproteinsmodulationofmultidrugresistantpseudomonasaeruginosastrainsisolatedfromcysticfibrosispatients
AT vrennagianluca ashavingproteomicapproachtounveilsurfaceproteinsmodulationofmultidrugresistantpseudomonasaeruginosastrainsisolatedfromcysticfibrosispatients
AT onettimudaandrea ashavingproteomicapproachtounveilsurfaceproteinsmodulationofmultidrugresistantpseudomonasaeruginosastrainsisolatedfromcysticfibrosispatients
AT putignanilorenza ashavingproteomicapproachtounveilsurfaceproteinsmodulationofmultidrugresistantpseudomonasaeruginosastrainsisolatedfromcysticfibrosispatients
AT fiscarelliersiliavita ashavingproteomicapproachtounveilsurfaceproteinsmodulationofmultidrugresistantpseudomonasaeruginosastrainsisolatedfromcysticfibrosispatients
AT montemariannalisa shavingproteomicapproachtounveilsurfaceproteinsmodulationofmultidrugresistantpseudomonasaeruginosastrainsisolatedfromcysticfibrosispatients
AT marzanovaleria shavingproteomicapproachtounveilsurfaceproteinsmodulationofmultidrugresistantpseudomonasaeruginosastrainsisolatedfromcysticfibrosispatients
AT essanour shavingproteomicapproachtounveilsurfaceproteinsmodulationofmultidrugresistantpseudomonasaeruginosastrainsisolatedfromcysticfibrosispatients
AT levimorterastefano shavingproteomicapproachtounveilsurfaceproteinsmodulationofmultidrugresistantpseudomonasaeruginosastrainsisolatedfromcysticfibrosispatients
AT rossittomartina shavingproteomicapproachtounveilsurfaceproteinsmodulationofmultidrugresistantpseudomonasaeruginosastrainsisolatedfromcysticfibrosispatients
AT gardinisimone shavingproteomicapproachtounveilsurfaceproteinsmodulationofmultidrugresistantpseudomonasaeruginosastrainsisolatedfromcysticfibrosispatients
AT selanlaura shavingproteomicapproachtounveilsurfaceproteinsmodulationofmultidrugresistantpseudomonasaeruginosastrainsisolatedfromcysticfibrosispatients
AT vrennagianluca shavingproteomicapproachtounveilsurfaceproteinsmodulationofmultidrugresistantpseudomonasaeruginosastrainsisolatedfromcysticfibrosispatients
AT onettimudaandrea shavingproteomicapproachtounveilsurfaceproteinsmodulationofmultidrugresistantpseudomonasaeruginosastrainsisolatedfromcysticfibrosispatients
AT putignanilorenza shavingproteomicapproachtounveilsurfaceproteinsmodulationofmultidrugresistantpseudomonasaeruginosastrainsisolatedfromcysticfibrosispatients
AT fiscarelliersiliavita shavingproteomicapproachtounveilsurfaceproteinsmodulationofmultidrugresistantpseudomonasaeruginosastrainsisolatedfromcysticfibrosispatients